Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Decernotinib

Generic Name: Decernotinib

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₁₉F_₃N_₆O

CAS Number: 944842-54-0

Unique Ingredient Identifier: MZK2GP0RHK

Overview

Decernotinib has been used in trials studying the treatment of Drug Interactions and Rheumatoid Arthritis.

Background

Decernotinib has been used in trials studying the treatment of Drug Interactions and Rheumatoid Arthritis.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects

Phase 1

Completed

Posted: 2013/06/25

Sponsor:Vertex Pharmaceutica...

ID:NCT01886209

A Phase 2/3 Open-label Extension Study to Evaluate Long-Term Safety and Efficacy With VX-509 in Subjects With Rheumatoid Arthritis

Phase 2

Completed

Posted: 2013/04/12

Sponsor:Vertex Pharmaceutica...

ID:NCT01830985

A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 Inhibitor

Phase 2

Completed

Posted: 2012/12/21

Sponsor:Vertex Pharmaceutica...

ID:NCT01754935

24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate

Phase 2

Completed

Posted: 2012/05/03

Sponsor:Vertex Pharmaceutica...

ID:NCT01590459

A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis

Phase 2

Completed

Posted: 2010/01/20

Sponsor:Vertex Pharmaceutica...

ID:NCT01052194

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy